CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma
暂无分享,去创建一个
M. Makishima | H. Nagase | K. Ando | T. Kamijo | Y. Suenaga | S. Wada | A. Yokoyama | T. Koshinaga | Shin'ichi Kobayashi | V. Cázares-Ordoñez | Yusuke Suenaga